Connor, Clark & Lunn Investment Management (CC&L)
HRTX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Heron Therapeutics HRTX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio HRTX Stock Details HRTX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
2025
Q4 		$122K Buy
2025
Q3 		$105K Buy
2023
Q1 		– Sell
2022
Q4 		$158K Sell
2022
Q3 		$965K Buy
2022
Q2 		– Sell
2022
Q1 		$720K Buy
2015
Q2 		– Sell
2015
Q1 		$541K Buy